(Q44301248)

1 December 2017

0 references

FDA use of the black box warning: time for reevaluation as a safety tool (English)

1 reference

1 December 2017

Bryan A Liang

1

1 reference

1 December 2017

language of work or name

1 reference

1 December 2002

1 reference

Journal of Clinical Anesthesia

1 December 2017

published in

1 reference

1 December 2017

volume

14

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

561-563

1 reference

Droperidol: should the black box be light gray?

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

Black-box warning for droperidol surprises pharmacists.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

Safety of newly approved drugs: implications for prescribing

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

Timing of new black box warnings and withdrawals for prescription medications

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

Thyroid Hormone Use: Trends in the United States from 1960 Through 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900444-0

7 January 2021

10.1016/S0952-8180(02)00444-0

Identifiers

DOI

1 reference

1 December 2017

1 reference